Analyse AbbVie stock

Confirmed: The consensus price target of 224.89 EUR is only around -1.4% below the current price of 228.18 EUR and is therefore clearly within the required ±25% plausibility range.
Quantitative: AbbVie trades at P/E ratio 29.57close to upper historical valuation range, which is partly justifiable due to defensive cash flows, high margins and pipeline premium. After the strong increase from the 52W low of 161.37 EUR to near the 52W high of 228.67 EUR, the upside potential seems limited in the short term; The price target therefore signals fair value/consolidation rather than significant undervaluation.
Fundamental:...